|
CMS
Publishes Program Year 2020 Open Payments Data
Applicable manufacturers and
Group Purchasing Organizations (GPOs) collectively reported $9.12 billion
publishable payments and ownership and investment interests to physicians and
teaching hospitals in Program Year 2020. Program Year 2020 accounts for
payments or transfers of value made between January 1, 2020 and December 31,
2020. Today, the Centers for Medicare &
Medicaid Services (CMS) published Open Payments Program Year 2020 data,
along with newly submitted and updated payment records for previous program
years. The data is accessible at https://openpaymentsdata.cms.gov/. Open Payments is a national disclosure
program that promotes transparency and accountability by making information
about the financial relationships between applicable manufacturers and group
purchasing organizations (GPOs) and physicians and teaching hospitals
available to the public. Through this program, the public has access to a
more transparent and accountable healthcare system. Program
Year 2020 Highlights
For Program Year 2020, CMS published $9.12
billion in payments and ownership and investment interests made by applicable
manufacturers and GPOs to physicians and teaching hospitals. This amount is
comprised of 6.38 million total records attributable to 487,152 physicians
and 1,213 teaching hospitals. Payments are reported in three payment
categories: general payments, research payments, and ownership or investment
interests. Payments in the three major reporting categories for Program Year
2020 are:
Over the past five years, there have been
consistent trends in the data. The research payment category consistently
leads in total dollar value reported across the three payment categories
followed by general payments and ownership and investment interest, payment
categories respectively. While these trends were also the case for Program
Year 2020, there was a noticeable difference in the reported dollar value
within general payment category. CMS is scheduled to refresh the Open
Payments data in early 2022 to reflect updates to the data made since this publication. For more information and resources, please
visit: https://www.cms.gov/openPayments Additional
Information – Program Year 2013 Data Now Archived
Beginning with the June 2021 data
publication, the Program Year 2013 data is closed and archived. Here is some
information on the closing and archiving process.
Contact
Us
For program related questions including
registration, review and dispute and data submission questions contact our
Help Desk at openpayments@cms.hhs.gov
or by phone at 1-855-326-8366 (TTY Line: 1-844-649-2766). The Help Desk is
open Monday through Friday, from 9:00am to 5:00pm (ET), excluding federal
holidays. Please note that all press inquiries should be submitted to the
CMS’ Press Office. Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on
Twitter @CMSGov. Creating Public Transparency of
Industry-Physician Financial Relationships.
|
Centers for Medicare &
Medicaid Services (CMS) has sent this update. To contact CMS go to our Contact Us page. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, June 30, 2021
CMS Publishes Program Year 2020 Open Payments Data
CMS Updates Medicare COVID-19 Snapshot
|
|||
|
|||
Today, the Centers for Medicare &
Medicaid Services (CMS) released a monthly update of data that provides a
snapshot of the impact of COVID-19 on the Medicare population. The updated
data show over 4.3 million COVID-19 cases among the Medicare population and
over 1.2 million COVID-19 hospitalizations. The updated snapshot covers the period from
January 1, 2020 to April 24, 2021. It is based on Medicare Fee-for-Service
claims and Medicare Advantage encounter data CMS received by May 21, 2021. To view the updated snapshot visit: https://www.cms.gov/research-statistics-data-systems/preliminary-medicare-covid-19-data-snapshot All of the above data
assets are also catalogued on Healthdata.gov: http://www.healthdata.gov/dataset/search
The Data Navigator development team
welcomes your feedback. Write to us at DataNavigator@cms.hhs.gov.
|
CMS released updated data quality information to the Data Quality Atlas Tool
|
Staying Safe in Extreme Heat
|
|
|
|
|
|
On the Record 06 30 2021
"You can imagine that the
burden will be borne disproportionately, and it will play out exactly the way
you think it will: The folks who currently struggle most with access to health
care are just going to be the greater proportion of those who will struggle in
the future."
— Michael Dill, director of workforce studies at the Association
of American Medical Colleges, spoke with AIS's Health Plan Weekly about how payers can work
to address the looming threat of a physician shortage.
Subscribers may read the Health Plan Weekly article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
The FDA last week granted...
...Roche's Actemra an emergency use authorization to treat both adult and juvenile patients hospitalized with COVID-19. The arthritis drug was previously approved for compassionate use, but can now be administered to COVID patients who require oxygen support, in tandem with corticosteroids. For the treatment of rheumatoid arthritis, the intravenous form of Actemra holds covered or better status for 93% of all insured lives under the medical benefit.
SOURCE: MMIT Analytics, as of 6/28/21Experts Predict Home Delivery of Rx Drugs Will Increase
Mail-order pharmacies garnered a larger-than-ever share of the
prescription drug business due to the pandemic.
Mail order will increase:
- "We're seeing a steady increase of mail
order," says Brian Anderson, a principal at Milliman Inc. He expects
that, in the next few years, delivered medication will account for half of
all fills, with at least 20% of total volume originating from mail-order
pharmacies.
- Anderson says Milliman's clients have seen mail order
grow and remain high. He adds that fills overall are up. In particular,
there are notable "increases in mental health categories, [like]
antidepressants," Anderson says.
Data varies:
- Steve Johnson, vice president of health outcomes at
Blue Cross Blue Shield affiliate-owned PBM Prime Therapeutics, says via
email that Prime has seen prescription dispensing return to a pre-pandemic
baseline in various categories.
- "For some of our Rx Collaborative employer
clients, mail order utilization has either remained flat or continues to
trend slightly downward since 2Q20. On average, our employers are seeing a
gradual decrease of 5 percentage points of mail prescriptions since
2Q20," Chantell Sell Regan, Pharm.D., national pharmacy practice
clinical lead at Willis Towers Watson, wrote in an email.
Rethink retail pharmacies:
- Anderson says that it's helpful to understand the shift
to mail order as a move to home delivery away from a strict retail
experience rather than a transition to mail-order pharmacy dispensing. He
expects that many fills will still originate in a retail pharmacy but will
be delivered after being filled.
- Ashraf Shehata, national sector lead for life sciences
at KPMG, says that PBMs have essentially become mail-order retailers, and
need to start thinking in a consumer-centric manner. A challenge for the
sector, he explains, "is rationalizing retail versus PBM"
operations.
From the blog: Meeting the Unique Needs of LGBTQ+ Older Adults
|
|
|
|
|
|
Tuesday, June 29, 2021
Stars and Stripes Daily Headlines
|
June
29, 2021 |
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|